Tech Company Financing Transactions
Ataraxis AI Funding Round
AIX Ventures, Bertelsmann Investments and Floating Point participated in a $20.4 million Series A funding round for Ataraxis AI. The financing was announced on 3/6/2025.
Transaction Overview
Company Name
Announced On
3/6/2025
Transaction Type
Venture Equity
Amount
$20,400,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to expand operations and its development efforts.
Company Information
Company Status
Private & Independent
Industry
Artificial Intelligence
Mailing Address
169 Madison Avenue 2274
New York, NY 10016
USA
New York, NY 10016
USA
Phone
Website
Email Address
Overview
We are dedicated to revolutionizing personalized medicine through innovative technology. Our mission is to empower physicians with advanced tools that pinpoint the most effective treatments, enhancing patient care and driving better health outcomes. Our team of world-class scientists, engineers, and physicians is transforming the medical landscape to ensure every patient receives personalized care. Backed by cutting-edge research and groundbreaking advancements in precision medicine, we're setting a new standard in healthcare.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jan Witowski
Chief Scientific Officer
Krzysztof Geras
Browse more venture capital transactions:
Prev: 3/6/2025: hema.to venture capital transaction
Next: 3/6/2025: Renaissance Fusion venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs